3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:百万円)

 

前連結会計年度

(2024年11月30日)

当連結会計年度

(2025年11月30日)

資産の部

 

 

流動資産

 

 

現金及び預金

6,101

10,190

受取手形、売掛金及び契約資産

16,703

18,858

電子記録債権

4,643

4,066

商品及び製品

6,136

8,041

仕掛品

1,866

1,650

原材料及び貯蔵品

2,403

2,514

その他

1,295

2,038

貸倒引当金

8

21

流動資産合計

39,141

47,339

固定資産

 

 

有形固定資産

 

 

建物及び構築物

10,560

10,910

減価償却累計額

6,723

7,024

建物及び構築物(純額)

3,837

3,885

機械装置及び運搬具

10,994

11,937

減価償却累計額

9,045

9,446

機械装置及び運搬具(純額)

1,949

2,491

工具、器具及び備品

4,454

5,088

減価償却累計額

3,166

3,601

工具、器具及び備品(純額)

1,288

1,486

土地

2,447

2,614

リース資産

355

384

減価償却累計額

224

191

リース資産(純額)

130

192

建設仮勘定

2,266

2,620

有形固定資産合計

11,920

13,291

無形固定資産

 

 

ソフトウエア

715

680

のれん

3,752

4,755

技術資産

439

404

顧客関連資産

1,617

1,412

その他

370

385

無形固定資産合計

6,893

7,638

投資その他の資産

 

 

投資有価証券

4,137

4,291

退職給付に係る資産

1,071

1,539

繰延税金資産

960

517

その他

494

848

貸倒引当金

23

24

投資その他の資産合計

6,639

7,172

固定資産合計

25,453

28,102

繰延資産

 

 

創立費

0

0

繰延資産合計

0

0

資産合計

64,595

75,441

 

 

 

 

(単位:百万円)

 

前連結会計年度

(2024年11月30日)

当連結会計年度

(2025年11月30日)

負債の部

 

 

流動負債

 

 

支払手形及び買掛金

9,272

9,551

電子記録債務

4,339

5,056

短期借入金

11,390

16,195

未払費用

3,166

3,493

未払法人税等

732

853

賞与引当金

684

815

製品保証引当金

58

23

災害損失引当金

14

その他

2,243

2,084

流動負債合計

31,903

38,074

固定負債

 

 

長期借入金

3,445

6,250

リース債務

86

141

繰延税金負債

909

309

株式報酬引当金

105

137

退職給付に係る負債

2,403

2,306

その他

439

823

固定負債合計

7,389

9,969

負債合計

39,293

48,043

純資産の部

 

 

株主資本

 

 

資本金

4,605

4,629

資本剰余金

6,320

6,344

利益剰余金

12,229

13,680

自己株式

255

255

株主資本合計

22,900

24,399

その他の包括利益累計額

 

 

その他有価証券評価差額金

1,388

1,438

繰延ヘッジ損益

2

0

為替換算調整勘定

319

458

退職給付に係る調整累計額

560

803

その他の包括利益累計額合計

2,265

2,699

非支配株主持分

136

298

純資産合計

25,302

27,397

負債純資産合計

64,595

75,441

 

E0258580950アステナホールディングス株式会社Astena Holdings Co., Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-12-012025-11-30FY2025-11-302023-12-012024-11-302024-11-301falsefalsefalse809502023-12-012024-11-30jppfs_cor:CapitalStockMember809502023-12-012024-11-30jppfs_cor:CapitalSurplusMember809502023-12-012024-11-30jppfs_cor:ShareholdersEquityMember809502023-12-012024-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502023-12-012024-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502023-12-012024-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502023-12-012024-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502023-12-012024-11-30jppfs_cor:RetainedEarningsMember809502024-11-30jppfs_cor:CapitalStockMember809502024-11-30jppfs_cor:CapitalSurplusMember809502024-11-30jppfs_cor:RetainedEarningsMember809502024-11-30jppfs_cor:TreasuryStockMember809502024-11-30jppfs_cor:ShareholdersEquityMember809502024-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502024-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502024-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502025-11-30jppfs_cor:CapitalSurplusMember809502025-11-30jppfs_cor:RetainedEarningsMember809502025-11-30jppfs_cor:TreasuryStockMember809502025-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502025-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502025-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502025-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502024-12-012025-11-30jppfs_cor:CapitalSurplusMember809502024-12-012025-11-30jppfs_cor:RetainedEarningsMember809502024-12-012025-11-30jppfs_cor:TreasuryStockMember809502024-12-012025-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502024-12-012025-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502024-12-012025-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502024-12-012025-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502025-11-30jppfs_cor:ShareholdersEquityMember809502025-11-30jppfs_cor:CapitalStockMember809502023-12-012024-11-30jppfs_cor:TreasuryStockMember809502023-11-30jppfs_cor:CapitalStockMember809502023-11-30jppfs_cor:CapitalSurplusMember809502023-11-30jppfs_cor:RetainedEarningsMember809502023-11-30jppfs_cor:TreasuryStockMember809502023-11-30jppfs_cor:ShareholdersEquityMember809502023-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502023-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502023-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502023-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502024-12-012025-11-30jppfs_cor:ShareholdersEquityMember809502024-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502025-11-30jppfs_cor:NonControllingInterestsMember809502024-12-012025-11-30jppfs_cor:NonControllingInterestsMember809502024-11-30jppfs_cor:NonControllingInterestsMember809502023-12-012024-11-30jppfs_cor:NonControllingInterestsMember809502023-11-30jppfs_cor:NonControllingInterestsMember809502025-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502024-12-012025-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502024-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-12-012024-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-12-012024-11-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember809502023-12-012024-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502025-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember809502024-12-012025-11-30jpcrp_cor:ReconcilingItemsMember809502023-12-012024-11-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember809502023-12-012024-11-30jpcrp_cor:ReconcilingItemsMember809502023-12-012024-11-30jpcrp_cor:ReportableSegmentsMember809502024-12-012025-11-30jppfs_cor:CapitalStockMember809502026-01-13809502025-11-30809502024-12-012025-11-30809502024-11-30809502023-12-012024-11-30809502023-11-30809502025-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502024-12-012025-11-30jpcrp_cor:ReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember809502024-12-012025-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502024-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502025-11-30jpcrp_cor:OtherReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:OtherReportableSegmentsMember809502024-11-30jpcrp_cor:OtherReportableSegmentsMember809502023-12-012024-11-30jpcrp_cor:OtherReportableSegmentsMemberxbrli:pureiso4217:JPY